TB-500 provides systemic benefits including whole-body inflammation reduction, enhanced cell migration, and improved tissue flexibility
Limiting time in aqueous solution reduces all degradation pathways, including any unexpected interactions
4.3 The potential of peptide-based redevelopment of dendritic cell vaccines After considerable endeavors, sipuleucel-T stands alone as the immunotherapeutic agent that has yielded a significant survival benefit in a randomized Phase 3 clinical trial (Kantoff et al., 2010)
Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth during repeated needle punctures for multi-dose vials
Their precautionary approach aligns with ours
Do not freeze, as this may compromise stability and effectiveness